(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

BD 231758 - Moxifloxacin Sensi-Disc 5mcg Precision Antimicrobial Susceptibility Testing Disc, 10/CA

BD  # 231758 - Moxifloxacin Sensi-Disc 5mcg  Precision Antimicrobial Susceptibility Testing Disc, 10/CA
Part Number BD 231758
SKU Number CIA1087901
Sell Unit CASE
Ships Within Special Order
List Price $161.21
Enter a valid quantity
Product Description

BD 231758 - Moxifloxacin Sensi-Disc 5mcg Precision Antimicrobial Susceptibility Testing Disc, 10/CA

The BD 231758 Moxifloxacin Sensi-Disc 5mcg is a high-quality antimicrobial susceptibility testing (AST) disc designed for evaluating bacterial response to moxifloxacin, a potent fluoroquinolone antibiotic. Each sterile disc contains 5 micrograms of moxifloxacin, ensuring consistent antibiotic diffusion and reproducible inhibition zones using the Kirby-Bauer disk diffusion method. Manufactured under BDs strict quality standards, this disc provides reliable performance for routine diagnostics, surveillance, and research applications.

Key Benefits

The BD Moxifloxacin 5mcg Sensi-Disc delivers sharp, well-defined inhibition zones essential for accurate AST interpretation. Its single-use sterile format minimizes contamination risk and supports high-throughput laboratory efficiency. BDs rigorous lot-to-lot quality controls guarantee stable potency and diffusion uniformity, providing dependable results when identifying fluoroquinolone resistance patterns in clinical isolates.

Compatibility and Applications

This AST disc is compatible with standard Mueller-Hinton agar used in CLSI- and EUCAST-aligned disk diffusion testing. It is commonly used for susceptibility testing in:

  • Staphylococcus aureus
  • Streptococcus pneumoniae (specific methods required)
  • Enterobacterales
  • Non-fermenting Gram-negative bacilli such as Pseudomonas aeruginosa
  • Respiratory pathogens evaluated for fluoroquinolone therapy

Moxifloxacin is widely used in respiratory, skin, soft-tissue, and intra-abdominal infection management, making this disc essential in routine clinical diagnostics.

Usage Guidelines

Prepare a 0.5 McFarland bacterial suspension and evenly inoculate a Mueller-Hinton agar plate. Apply the BD 231758 disc using sterile forceps or a disc dispenser. Incubate at 3537C for 1620 hours unless organism-specific conditions differ. Measure the zone of inhibition and interpret results according to the latest CLSI or EUCAST breakpoints. Store discs at 28C in sealed containers with desiccant to preserve potency.

Certifications, Safety Standards, and Regulatory Approvals

The BD 231758 Moxifloxacin Sensi-Disc is manufactured under ISO 9001 and ISO 13485 certified quality systems and complies with FDA and CE regulatory requirements for in vitro diagnostic (IVD) materials. Each lot undergoes testing for antibiotic content, sterility, diffusion consistency, and long-term stability.

Comparison with Competitor Products

BD Sensi-Discs consistently outperform generic brands through superior antibiotic stability and more defined diffusion patterns. Competing discs may show variable potency or uneven antibiotic distribution, leading to inconsistent AST results. BDs advanced manufacturing ensures accuracy, reliability, and enhanced clinical confidence in susceptibility interpretations.

Typical User Profile and Application Scenarios

This disc is widely used by:

  • Clinical microbiologists in hospital and reference labs
  • Infectious disease testing units evaluating fluoroquinolone efficacy
  • Public health surveillance programs monitoring resistance trends
  • Academic and research laboratories studying antibiotic resistance mechanisms

Best Practices for Use and Maintenance

Allow refrigerated discs to reach room temperature before opening to avoid condensation. Handle only with sterile forceps, and minimize exposure to ambient humidity. Use approved QC organismssuch as Staphylococcus aureus ATCC 25923 and E. coli ATCC 25922to ensure test validity. Discard expired or moisture-damaged discs immediately.

Regulatory and Safety Information

The BD 231758 Sensi-Disc is intended for in vitro diagnostic use by trained laboratory professionals. Follow biosafety level 2 practices when handling clinical isolates. Wear appropriate PPE and dispose of used discs, plates, and materials as regulated biohazard waste.

How to Order

To order the BD 231758 Moxifloxacin Sensi-Disc 5mcg, add the item to your cart and complete the order through CIA Medicals secure checkout system. For bulk orders, supply agreements, or additional assistance, contact CIA Medical customer service at (312) 275-5850 or use the inquiry form on this page for support.